Viewing data from:

SSD

NDA

SILVER SULFADIAZINE | N018578 | DR REDDYS LABORATORIES INC

2 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Medicare Part D Spending

CMS annual spending data for Ssd (2023)

Total Spending

$4.6M

Total Claims

222,662

Beneficiaries

153,462

Avg Cost/Unit

$0.13

Spending Trend

$6.5M(2019)→$5.9M(2020)→$5.7M(2021)→$5.6M(2022)→$4.6M(2023)

YoY Change:-3.2%

5yr CAGR:-4.0%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain6 active DMFs5 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

LEK PHARMACEUTICALS DDSILVER SULFADIAZINE

DMF 42971981

TAPI NL BVSILVER SULFADIAZINE

DMF 116621995

AMISHI DRUGS AND CHEMICALS PVT LTDSILVER SULFADIAZINE USP

DMF 220832008

LUSOCHIMICA SPASILVER SULFADIAZINE

DMF 291142015

INDIA PHOSPHATE AND ALLIED INDUSTRIES PRIVATE LTDSILVER SULFADIAZINE USP

DMF 292292015

MACSEN DRUGSSILVER SULFADIAZINE USP

DMF 330522018

MALLINCKRODT INCInactiveSILVER SULFADIAZINE

DMF 20131972

NAPP CHEMICALS INCInactiveSILVER SULFADIAZINE

DMF 41871981

FINE CHEMICALS CORPInactiveSILVER SULFADIAZINE

DMF 59081985

DSM ANDENO GMBHInactiveSILVER SULFADIAZINE

DMF 61501986

DSM MINERA BVInactiveSILVER SULFADIAZINE

DMF 147572000

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 1%

RLDAB

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: Feb 25, 1982

No patent or exclusivity listings for this strength.

#003 — 1%

0 patents0 exclusivities▾

CREAM;TOPICAL | Approved: Jul 11, 1990